These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6526731)

  • 1. Syntheses of 23-deoxy-23-N-ethyl-23-(2-fluoro-, 2,2-difluoro-, and 2,2,2-trifluoroethyl)amino derivatives of mycaminosyl tylonolide and 4'-deoxymycaminosyl tylonolide.
    Sakamoto S; Tsuchiya T; Tanaka A; Umezawa S; Hamada M; Umezawa H
    J Antibiot (Tokyo); 1984 Dec; 37(12):1628-34. PubMed ID: 6526731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Syntheses of derivatives of 4'-deoxymycaminosyl tylonolide and mycaminosyl tylonolide modified AT C-23.
    Tanaka A; Tsuchiya T; Umezawa S; Hamada M; Umezawa H
    J Antibiot (Tokyo); 1981 Oct; 34(10):1377-80. PubMed ID: 7309634
    [No Abstract]   [Full Text] [Related]  

  • 3. Syntheses of 23-dialkylamino derivatives of mycaminosyl tylonolide and 4'-deoxymycaminosyl tylonolide effective against gram-negative bacteria.
    Tanaka A; Tsuchiya T; Okada Y; Umezawa S; Hamada M; Umezawa H
    J Antibiot (Tokyo); 1982 Jan; 35(1):113-6. PubMed ID: 7068511
    [No Abstract]   [Full Text] [Related]  

  • 4. Synthesis of 4'-deoxymycaminosyl tylonolide.
    Tanaka A; Tsuchiya T; Umezawa S; Umezawa H
    J Antibiot (Tokyo); 1981 Oct; 34(10):1374-6. PubMed ID: 7309633
    [No Abstract]   [Full Text] [Related]  

  • 5. N-Substituted derivatives of 23-amino-4',23-dideoxymycaminosyl tylonolide. Synthesis and antibacterial activity.
    Sakamoto S; Tsuchiya T; Tanaka A; Umezawa S; Hamada M; Umezawa H
    J Antibiot (Tokyo); 1985 Apr; 38(4):477-84. PubMed ID: 4008340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of 3-deoxy-3,4-didehydro derivatives of 5-O-mycaminosyltylonolide, 5-O-(4-deoxymycaminosyl) tylonolide, and desmycosin.
    Kageyama S; Tsuchiya T; Umezawa S
    J Antibiot (Tokyo); 1993 Aug; 46(8):1265-78. PubMed ID: 8407589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Syntheses of 23-C-substituted derivatives of mycaminosyl tylonolide.
    Tsuchiya T; Sakamoto S; Kajikawa N; Umezawa S; Hamada M; Umezawa H
    J Antibiot (Tokyo); 1986 Jul; 39(7):1021-4. PubMed ID: 3759646
    [No Abstract]   [Full Text] [Related]  

  • 8. Syntheses of 4'-deoxy-demycarosyl tylosin and its analogues.
    Tanaka A; Watanabe A; Tsuchiya T; Umezawa S; Umezawa H
    J Antibiot (Tokyo); 1981 Oct; 34(10):1381-4. PubMed ID: 7309635
    [No Abstract]   [Full Text] [Related]  

  • 9. Syntheses and antimicrobial activities of 9-O-acyl derivatives of tylosin and demycarosyltylosin.
    Tsuzuki K; Matsubara H; Nakagawa A; Omura S
    J Antibiot (Tokyo); 1986 Dec; 39(12):1784-7. PubMed ID: 3818453
    [No Abstract]   [Full Text] [Related]  

  • 10. Tylonolide hemiacetal, the aglycone of tylosin, and its partial synthesis.
    Masamune S; Hayase Y; Chan WK; Sobzak RL
    J Am Chem Soc; 1976 Nov; 98(24):7874-5. PubMed ID: 993508
    [No Abstract]   [Full Text] [Related]  

  • 11. Formation of an antibacterial metabolite from a new macrolide compound 23-O-benzyl-5-mycaminosyl-tylonolide (TMC-101), by a hepatic microsomal drug-metabolizing enzyme system.
    Nakura H; Ohi H; Miura T; Fujiwara T; Ishizone H; Yokoi T; Kitada M; Kamataki T
    J Pharmacobiodyn; 1991 Jul; 14(7):377-83. PubMed ID: 1802985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of tylosin and its derivatives against Ureaplasma urealyticum.
    Zuzulova M; Kleinova D; Proksa B; Fuska J
    Arzneimittelforschung; 1995 Nov; 45(11):1222-4. PubMed ID: 8929244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Syntheses of 23-C-alkylidene, and 23-N-containing derivatives of 5-O-mycaminosyltylonolide.
    Kajikawa N; Tsuchiya T; Umezawa S; Umezawa H
    J Antibiot (Tokyo); 1987 Apr; 40(4):476-82. PubMed ID: 3583916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visualizing the 16-membered ring macrolides tildipirosin and tilmicosin bound to their ribosomal site.
    Poehlsgaard J; Andersen NM; Warrass R; Douthwaite S
    ACS Chem Biol; 2012 Aug; 7(8):1351-5. PubMed ID: 22563863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioconversion of 19-deformyl-5-O-desosaminyl tylonolide to 19-deformyl-4'-deoxydesmycosin (TMC-016).
    Fujiwara T; Takenaka S
    FEMS Microbiol Lett; 1990 May; 57(1-2):101-3. PubMed ID: 2379808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemical modification of tylosin: synthesis of amino derivatives at C-20 position of tylosin and demycarosyltylosin.
    Matsubara H; Inokoshi J; Nakagawa A; Tanaka H; Omura S
    J Antibiot (Tokyo); 1983 Dec; 36(12):1713-21. PubMed ID: 6662813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel dimeric derivatives of leucomycins and tylosin, sixteen-membered macrolides.
    Omura S; Miyano K; Matsubara H; Nakagawa A
    J Med Chem; 1982 Mar; 25(3):271-5. PubMed ID: 7040661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-O-Mycaminosyltylonolide antibacterial derivatives: design, synthesis and bioactivity.
    Sugawara A; Maruyama H; Shibusawa S; Matsui H; Hirose T; Tsutsui A; Froyman R; Ludwig C; Koebberling J; Hanaki H; Kleefeld G; Ōmura S; Sunazuka T
    J Antibiot (Tokyo); 2017 Jul; 70(8):878-887. PubMed ID: 28559578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical modification of tylosin. Thioether derivatives of tylosin and demycarosyltylosin.
    Omura S; Matsubara H; Tsuzuki K; Nakagawa A
    J Antibiot (Tokyo); 1984 Sep; 37(9):1007-15. PubMed ID: 6501102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and antimicrobial evaluation of 20-deoxo-20-(3,5-dimethylpiperidin-1-yl)desmycosin (tilmicosin, EL-870) and related cyclic amino derivatives.
    Debono M; Willard KE; Kirst HA; Wind JA; Crouse GD; Tao EV; Vicenzi JT; Counter FT; Ott JL; Ose EE
    J Antibiot (Tokyo); 1989 Aug; 42(8):1253-67. PubMed ID: 2668243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.